BAY2328065
/ Bayer, Evotec
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
April 13, 2022
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
(clinicaltrials.gov)
- P1 | N=31 | Completed | Sponsor: Bayer | Active, not recruiting ➔ Completed
Trial completion • Endometriosis • Gynecology
December 07, 2021
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
(clinicaltrials.gov)
- P1; N=31; Active, not recruiting; Sponsor: Bayer; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Endometriosis • Gynecology
May 19, 2021
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
(clinicaltrials.gov)
- P1; N=32; Recruiting; Sponsor: Bayer; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Endometriosis • Gynecology
April 20, 2021
A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants
(clinicaltrials.gov)
- P1; N=32; Not yet recruiting; Sponsor: Bayer
New P1 trial • Endometriosis • Gynecology
November 23, 2020
Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.
(clinicaltrials.gov)
- P1; N=50; Completed; Sponsor: Bayer; Active, not recruiting ➔ Completed
Clinical • Trial completion • Endometriosis • Gynecology
September 18, 2020
Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.
(clinicaltrials.gov)
- P1; N=50; Active, not recruiting; Sponsor: Bayer; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Endometriosis • Gynecology
August 19, 2019
Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.
(clinicaltrials.gov)
- P1; N=60; Recruiting; Sponsor: Bayer; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open
July 19, 2019
Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.
(clinicaltrials.gov)
- P1; N=60; Not yet recruiting; Sponsor: Bayer
Clinical • New P1 trial
1 to 8
Of
8
Go to page
1